Insider Selling: ReposiTrak (NYSE:TRAK) CEO Sells 1,200 Shares of Stock

Key Points

• Randall Fields, CEO of ReposiTrak, sold 1,200 shares of the company's stock at an average price of $16.06, reducing his ownership by 1.89% to a total of 62,200 shares valued at approximately $999,000.
• ReposiTrak's stock is currently trading at $15.72 with a market capitalization of $287.36 million, a PE ratio of 44.92, and significant institutional investor interest, with 27.35% of the company's stock owned by institutional investors.
• The company reported quarterly earnings of $0.09 EPS with revenues of $5.76 million, and has shown stable financial ratios, including a current ratio and quick ratio of 6.03, indicating strong liquidity.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 1,200 shares of the company's stock in a transaction on Tuesday, September 30th. The shares were sold at an average price of $16.06, for a total value of $19,272.00. Following the completion of the transaction, the chief executive officer directly owned 62,200 shares in the company, valued at $998,932. This trade represents a 1.89% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

ReposiTrak Stock Performance

ReposiTrak stock traded up $0.90 during mid-day trading on Wednesday, hitting $15.72. The company's stock had a trading volume of 178,124 shares, compared to its average volume of 51,851. The company has a 50 day simple moving average of $16.81. The company has a market capitalization of $287.36 million, a PE ratio of 44.92 and a beta of 0.47. The company has a current ratio of 6.03, a quick ratio of 6.03 and a debt-to-equity ratio of 0.01. ReposiTrak Inc. has a one year low of $13.86 and a one year high of $25.01.

ReposiTrak (NYSE:TRAK - Get Free Report) last announced its quarterly earnings data on Monday, September 29th. The company reported $0.09 EPS for the quarter. The company had revenue of $5.76 million for the quarter. ReposiTrak had a return on equity of 14.35% and a net margin of 30.55%.

Hedge Funds Weigh In On ReposiTrak

Several hedge funds have recently bought and sold shares of TRAK. BNP Paribas Financial Markets grew its position in ReposiTrak by 63.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock valued at $32,000 after acquiring an additional 634 shares during the last quarter. Tower Research Capital LLC TRC lifted its holdings in shares of ReposiTrak by 397.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock worth $71,000 after buying an additional 2,892 shares during the period. R Squared Ltd purchased a new stake in shares of ReposiTrak in the 2nd quarter worth $235,000. Rhumbline Advisers lifted its holdings in shares of ReposiTrak by 69.1% in the 2nd quarter. Rhumbline Advisers now owns 18,036 shares of the company's stock worth $354,000 after buying an additional 7,371 shares during the period. Finally, Coldstream Capital Management Inc. lifted its holdings in shares of ReposiTrak by 47,619.0% in the 2nd quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock worth $394,000 after buying an additional 20,000 shares during the period. Institutional investors own 27.35% of the company's stock.

About ReposiTrak

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.